He X, Shi M, Zhang L, Zhan J, et al. Baseline tumor burden predicts the efficacy of first-line chemoimmunotherapy in patients with advanced non-small cell lung cancer: results from 2 phase 3 randomized placebo-controlled trials. BMC Cancer 2025;25:1380.
PMID: 40866864